查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1943706

透析中心市场 - 全球产业规模、份额、趋势、竞争格局、机会及预测（按所有权、透析类型、服务、地区和竞争情况划分），2021-2031年

Dialysis Center Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, Segmented By Ownership, By Type of Dialysis, By Service, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球透析中心市场预计将从 2025 年的 1,102.5 亿美元成长到 2031 年的 1,478.3 亿美元，年复合成长率为 5.01%。

这些专业设施对于为末期肾功能衰竭患者提供肾臟替代疗法（例如血液透析和腹膜透析）至关重要。市场成长趋势的主要驱动力是全球慢性肾臟病，而人口老化以及糖尿病和高血压发病率的飙升是造成这一趋势的重要因素。这导致迫切需要建立持久的长期照护基础设施，以满足日益增长的患者需求。根据美国国家肾臟基金会的报告显示，到2024年，美国预计将有3,550万成年人患有慢性肾臟病，凸显了提供便利肾臟护理服务的紧迫性。

市场概览
预测期 2027-2031
市场规模：2025年 1102.5亿美元
市场规模：2031年 1478.3亿美元
复合年增长率：2026-2031年 5.01%
成长最快的细分市场 血液透析
最大的市场 北美洲

儘管市场需求旺盛，但由于建立和维护透析中心的成本高昂，市场扩张面临许多挑战。除了需要大量资金购买专用设备、水质净化系统和医疗耗材外，合格的肾臟科护理师和技师在全球范围内也面临短缺，医疗服务提供者难以招募足够的人员。公共医疗体系中停滞不前且复杂的薪资结构进一步加剧了这些财务压力，造成了严峻的经济环境。这些营运限制可能会阻碍新设施的建设，并限制经济欠发达地区关键服务的可近性。

市场驱动因素

推动透析中心市场发展的主要因素是全球慢性肾臟病和末期肾功能衰竭，这主要是由于糖尿病和高血压的日益普遍。随着这些文明病相关疾病的日益流行，肾功能下降速度加快，对肾臟替代疗法的需求持续增加。这一趋势导致依赖血液透析和腹膜透析维持生命的患者数量不断增加。代谢性疾病与肾衰竭之间的关联至关重要，需要大规模的基础设施建设来应对不断增长的病例数。例如，美国国家肾臟基金会于2024年5月发布的一份报告估计，大约三分之一的糖尿病成人患者会患上慢性肾臟病，这凸显了合併症对肾臟健康的严重影响以及由此产生的对专业护理的需求。

此外，肾臟捐赠者严重短缺，导致透析服务亟需扩充。许多患者依赖透析服务，或将其作为等待移植的临时措施，或作为永久解决方案。器官移植需求患者数量与捐赠器官供应有限之间存在巨大缺口，迫使患者长期接受透析治疗，加剧了现有透析设施的使用。根据联合国器官移植网络（UNOS）的数据，截至2025年1月，美国约有9万人等待肾臟移植，凸显了根治性治疗的瓶颈。这一缺口确保了医疗服务提供者拥有稳定的患者群体，DaVita公司于2025年2月发布的数据也印证了这一点（截至2024年底，该公司在全球为约281,100名患者提供服务）。

市场挑战

由于建立和营运透析中心会带来沉重的财务负担，透析中心市场的扩张面临严峻的挑战。当前充满挑战的经济环境，以及对专用设备和水处理系统的高资本投资，持续挤压着业者的利润空间。这种财务不稳定主要是由于不断上涨的营运成本与公共医疗保险机构固定报销率之间的差距日益扩大。当治疗成本超过每次治疗的收入时，机构将被迫暂停扩张，甚至可能被迫关闭经济欠发达地区的诊所，从而限制市场准入。

由于劳动力严重短缺导致人事费用人为上涨，加剧了这种经济压力。为了吸引和留住所需的肾内科护理师和技师，医疗机构必须支付更高的工资，但这些增加的成本并未被收入的成长所抵消。根据透析患者公民协会的数据，到2024年，医疗机构的人事费用在过去两年中增加了9.7%，而联邦医疗保险（Medicare）的报销率仅增加了1.7%。这种不可持续的财务差距阻碍了医疗机构对新基础设施的投资，并抑制了全球市场的整体发展。

市场趋势

透析产业正经历重大变革时期，从计量型模式转向基于价值的医疗服务模式，这从根本上改变了其营运策略。透析服务提供者越来越注重患者的治疗效果，例如减少再入院率和延缓疾病进展，而不是仅仅追求治疗量。这种转变推动了整合式医疗合约的普及，在这种合约下，医疗机构承担患者整体健康的财务风险，这要求他们与肾臟科医生和基层医疗医生更紧密地合作。例如，DaVita 在其于 2025 年 2 月发布的「2024 年第四季财务表现」报告中指出，截至 2024 年底，该公司将根据基于风险的整合式医疗合约管理约 70,400 名患者，这凸显了大型服务提供者对这些基于绩效的支付模式的快速采用。

同时，居家透析培训和支援的扩展正在重新定义传统诊所的角色和物理结构。透析中心正在转型为教育和后勤枢纽，为选择腹膜透析和居家血液透析的患者提供必要的培训、设备和远端监测。这一趋势使医疗机构能够透过管理费和培训费获得收入，同时满足患者日益增长的自主性和生活方式柔软性的需求。根据美国肾臟数据系统于2025年1月发布的《2024年数据报告》，约有15%的新发和现有末期肾功能衰竭患者正在接受居家治疗方法，这使得他们对医疗机构支持这种分散式护理模式的依赖性日益增强。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球透析中心市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依所有权类型（独立运作与医院附属运作）
    • 依透析类型（血液透析和腹膜透析）
    • 依服务类型（院内/住院 vs.门诊病人）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

6. 北美透析中心市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲透析中心市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区透析中心市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东和非洲透析中心市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲透析中心市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球透析中心市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Fresenius Medical Care AG & Co. KGaA
  • DaVita Inc.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Nipro Corporation
  • Renal Ventures Management, LLC
  • US Renal Care, Inc.
  • Dialysis Clinics, Inc.
  • MEDICARE Health Partners
  • Asahi Kasei Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 8026

The Global Dialysis Center Market is projected to expand from USD 110.25 Billion in 2025 to USD 147.83 Billion by 2031, reflecting a compound annual growth rate of 5.01%. These specialized facilities are essential for providing renal replacement therapies, such as hemodialysis and peritoneal dialysis, to patients suffering from end-stage renal disease. The market's upward trajectory is primarily caused by the increasing global prevalence of chronic kidney conditions, a trend heavily influenced by aging demographics and the surging rates of diabetes and hypertension. Consequently, there is a pressing need for durable, long-term care infrastructure to accommodate the rising patient numbers. As reported by the National Kidney Foundation, an estimated 35.5 million adults in the United States were living with chronic kidney disease in 2024, emphasizing the urgent demand for accessible renal care services.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 110.25 Billion
Market Size 2031USD 147.83 Billion
CAGR 2026-20315.01%
Fastest Growing SegmentHemodialysis
Largest MarketNorth America

Despite this demand, market expansion faces significant hurdles due to the high costs involved in establishing and maintaining dialysis centers. Providers grapple with the substantial capital required for specialized equipment, water purification systems, and medical consumables, alongside a global scarcity of qualified nephrology nurses and technicians. These financial pressures are often exacerbated by stagnant or complicated reimbursement structures within public health systems, creating a challenging economic environment. Such operational constraints can hinder the development of new facilities and restrict the availability of critical services in economically constrained regions.

Market Driver

The primary force driving the dialysis center market is the growing global incidence of chronic kidney disease and end-stage renal disease, which is largely propelled by increasing rates of diabetes and hypertension. As these lifestyle-associated conditions become more common, they hasten the decline of kidney function, resulting in a persistent demand for renal replacement therapies. This trend ensures a steady stream of patients who depend on life-sustaining hemodialysis or peritoneal dialysis. The link between metabolic disorders and kidney failure is significant, requiring extensive infrastructure to manage the rising caseload. For instance, the National Kidney Foundation reported in May 2024 that approximately one in three adults with diabetes was estimated to have chronic kidney disease, highlighting the profound effect of comorbidities on renal health and the subsequent need for specialized care.

Furthermore, the critical scarcity of kidney donors mandates the expansion of dialysis services, as many patients must rely on these centers either as a temporary measure while awaiting a transplant or as a permanent solution. The vast gap between the number of patients needing organ replacement and the limited supply of donor organs compels individuals to stay on dialysis for prolonged periods, thereby increasing the utilization of existing facilities. According to the United Network for Organ Sharing, nearly 90,000 individuals in the United States were on the kidney transplant waiting list in January 2025, illustrating the bottleneck in curative treatments. This gap ensures consistent patient volumes for providers, as evidenced by DaVita Inc., which reported in February 2025 that it served approximately 281,100 patients worldwide by the end of 2024.

Market Challenge

The expansion of the dialysis center market is severely threatened by the significant financial burdens involved in setting up and running facilities. Providers encounter a rigid economic environment characterized by high capital expenditures for specialized machinery and water treatment systems, which continuously squeeze operating margins. This financial precarity stems largely from the growing gap between escalating operational costs and flat reimbursement rates from public health payers. When the expense of providing treatment outstrips the revenue earned per session, organizations are compelled to pause capacity growth and may even be forced to shut down clinics in economically disadvantaged areas, thereby restricting market access.

This economic strain is intensified by severe workforce shortages that artificially drive up labor expenses. To attract and keep necessary nephrology nurses and technicians, facilities are required to pay higher wages; however, these increased costs are not met with proportional revenue increases. Data from Dialysis Patient Citizens indicates that in 2024, labor costs for providers rose by 9.7% over the previous two years, while Medicare reimbursement rates increased by only 1.7%. This unsustainable financial disparity hinders providers from investing in new infrastructure and impedes the overall development of the global market.

Market Trends

The industry is undergoing a significant transformation as it moves from traditional fee-for-service models toward value-based healthcare delivery, fundamentally altering operational strategies. Dialysis providers are increasingly motivated to focus on patient outcomes, such as minimizing hospital readmissions and slowing disease progression, rather than simply increasing treatment volumes. This evolution supports the adoption of integrated care contracts where centers accept financial risk for a patient's overall health, requiring closer collaboration with nephrologists and primary care providers. As an example of this shift, DaVita Inc. reported in its '4th Quarter 2024 Results' in February 2025 that it was managing roughly 70,400 patients under risk-based integrated care arrangements by the end of 2024, highlighting the speed at which major providers are embracing these outcome-focused payment models.

Simultaneously, the growth of home dialysis training and support is redefining the role and physical structure of traditional clinics. Dialysis centers are evolving into educational and logistical hubs that supply the necessary training, equipment, and remote monitoring for patients who choose peritoneal dialysis or home hemodialysis. This trend enables facilities to generate revenue through management fees and training reimbursements while satisfying the rising patient desire for greater autonomy and lifestyle flexibility. According to the '2024 Annual Data Report' released by the United States Renal Data System in January 2025, approximately 15% of new and existing end-stage renal disease patients were using home-based modalities, demonstrating the growing reliance on centers to support this decentralized approach to care.

Key Market Players

  • Fresenius Medical Care AG & Co. KGaA
  • DaVita Inc.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Nipro Corporation
  • Renal Ventures Management, LLC
  • U.S. Renal Care, Inc.
  • Dialysis Clinics, Inc.
  • MEDICARE Health Partners
  • Asahi Kasei Corporation

Report Scope

In this report, the Global Dialysis Center Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dialysis Center Market, By Ownership

  • Standalone v/s Hospital-Based

Dialysis Center Market, By Type of Dialysis

  • Hemodialysis v/s Peritoneal Dialysis

Dialysis Center Market, By Service

  • In-Center/Inpatient v/s Outpatient

Dialysis Center Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dialysis Center Market.

Available Customizations:

Global Dialysis Center Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dialysis Center Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Ownership (Standalone v/s Hospital-Based)
    • 5.2.2. By Type of Dialysis (Hemodialysis v/s Peritoneal Dialysis)
    • 5.2.3. By Service (In-Center/Inpatient v/s Outpatient)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Dialysis Center Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Ownership
    • 6.2.2. By Type of Dialysis
    • 6.2.3. By Service
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Dialysis Center Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Ownership
        • 6.3.1.2.2. By Type of Dialysis
        • 6.3.1.2.3. By Service
    • 6.3.2. Canada Dialysis Center Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Ownership
        • 6.3.2.2.2. By Type of Dialysis
        • 6.3.2.2.3. By Service
    • 6.3.3. Mexico Dialysis Center Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Ownership
        • 6.3.3.2.2. By Type of Dialysis
        • 6.3.3.2.3. By Service

7. Europe Dialysis Center Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Ownership
    • 7.2.2. By Type of Dialysis
    • 7.2.3. By Service
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Dialysis Center Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Ownership
        • 7.3.1.2.2. By Type of Dialysis
        • 7.3.1.2.3. By Service
    • 7.3.2. France Dialysis Center Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Ownership
        • 7.3.2.2.2. By Type of Dialysis
        • 7.3.2.2.3. By Service
    • 7.3.3. United Kingdom Dialysis Center Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Ownership
        • 7.3.3.2.2. By Type of Dialysis
        • 7.3.3.2.3. By Service
    • 7.3.4. Italy Dialysis Center Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Ownership
        • 7.3.4.2.2. By Type of Dialysis
        • 7.3.4.2.3. By Service
    • 7.3.5. Spain Dialysis Center Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Ownership
        • 7.3.5.2.2. By Type of Dialysis
        • 7.3.5.2.3. By Service

8. Asia Pacific Dialysis Center Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Ownership
    • 8.2.2. By Type of Dialysis
    • 8.2.3. By Service
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Dialysis Center Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Ownership
        • 8.3.1.2.2. By Type of Dialysis
        • 8.3.1.2.3. By Service
    • 8.3.2. India Dialysis Center Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Ownership
        • 8.3.2.2.2. By Type of Dialysis
        • 8.3.2.2.3. By Service
    • 8.3.3. Japan Dialysis Center Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Ownership
        • 8.3.3.2.2. By Type of Dialysis
        • 8.3.3.2.3. By Service
    • 8.3.4. South Korea Dialysis Center Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Ownership
        • 8.3.4.2.2. By Type of Dialysis
        • 8.3.4.2.3. By Service
    • 8.3.5. Australia Dialysis Center Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Ownership
        • 8.3.5.2.2. By Type of Dialysis
        • 8.3.5.2.3. By Service

9. Middle East & Africa Dialysis Center Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Ownership
    • 9.2.2. By Type of Dialysis
    • 9.2.3. By Service
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Dialysis Center Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Ownership
        • 9.3.1.2.2. By Type of Dialysis
        • 9.3.1.2.3. By Service
    • 9.3.2. UAE Dialysis Center Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Ownership
        • 9.3.2.2.2. By Type of Dialysis
        • 9.3.2.2.3. By Service
    • 9.3.3. South Africa Dialysis Center Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Ownership
        • 9.3.3.2.2. By Type of Dialysis
        • 9.3.3.2.3. By Service

10. South America Dialysis Center Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Ownership
    • 10.2.2. By Type of Dialysis
    • 10.2.3. By Service
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Dialysis Center Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Ownership
        • 10.3.1.2.2. By Type of Dialysis
        • 10.3.1.2.3. By Service
    • 10.3.2. Colombia Dialysis Center Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Ownership
        • 10.3.2.2.2. By Type of Dialysis
        • 10.3.2.2.3. By Service
    • 10.3.3. Argentina Dialysis Center Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Ownership
        • 10.3.3.2.2. By Type of Dialysis
        • 10.3.3.2.3. By Service

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Dialysis Center Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Fresenius Medical Care AG & Co. KGaA
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. DaVita Inc.
  • 15.3. Baxter International Inc.
  • 15.4. B. Braun Melsungen AG
  • 15.5. Nipro Corporation
  • 15.6. Renal Ventures Management, LLC
  • 15.7. U.S. Renal Care, Inc.
  • 15.8. Dialysis Clinics, Inc.
  • 15.9. MEDICARE Health Partners
  • 15.10. Asahi Kasei Corporation

16. Strategic Recommendations

17. About Us & Disclaimer